(Q45755873)

15 December 2017

title

Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection (English)

1 reference

15 December 2017

feline immunodeficiency virus

main subject

object named as

Feline immunodeficiency virus

1 reference

8

Osterhaus AD

1 reference

15 December 2017

author name string

Huisman W

1

1 reference

15 December 2017

Karlas JA

2

1 reference

15 December 2017

Siebelink KH

3

1 reference

15 December 2017

Huisman RC

4

1 reference

15 December 2017

de Ronde A

5

1 reference

15 December 2017

Francis MJ

6

1 reference

15 December 2017

Rimmelzwaan GF

7

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

16

1 reference

15 December 2017

issue

2-3

1 reference

15 December 2017

page(s)

181-187

1 reference

15 December 2017

Feline immunodeficiency virus (FIV) infection in the cat as a model for HIV infection in man: FIV-induced impairment of immune function

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

Experimental vaccine protection against feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

Passive antibody protection of cats against feline immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

Enhancement after feline immunodeficiency virus vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

Suppression of virus burden by immunization with feline immunodeficiency virus Env protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

A determinant of feline immunodeficiency virus involved in Crandell feline kidney cell tropism

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

Removal of the cleavage site of recombinant feline immunodeficiency virus envelope protein facilitates incorporation of the surface glycoprotein in immune-stimulating complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

High-level expression of recombinant genes in Escherichia coli is dependent on the availability of the dnaY gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

Soluble proteins incorporate into ISCOMs after covalent attachment of fatty acid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

Antigenicity and immunogenicity of recombinant envelope glycoproteins of SIVmac32H with different in vivo passage histories

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

Antibody response in cats to the envelope proteins of feline immunodeficiency virus: identification of an immunodominant neutralization domain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

Neutralization sensitivity and accessibility of continuous B cell epitopes of the feline immunodeficiency virus envelope.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

Enhancement of infectivity of a non-syncytium inducing HIV-1 by sCD4 and by human antibodies that neutralize syncytium inducing HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900184-9

7 January 2021

10.1016/S0264-410X(97)00184-9

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017